Clinical investigation of medicinal products used in the treatment of osteoarthritis

  • Email
  • Help
Current effective version

Revision 1 - Adopted guideline

Reference numberCPMP/EWP/784/97 Rev. 1
Effective from01/08/2010
KeywordsOsteoarthritis, symptom modifying drugs, structure modifying drugs, non-steroidal anti-inflammatory drugs (NSAIDs), clinical development
DescriptionThis document provides guidance on the clinical evaluation of medicinal products in the treatment of osteoarthritis.

Document history

Revision 1 

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/08/2010–present

Published: 01/02/2010

Published: 23/04/2009

Published: 24/04/2008

Related content

How helpful is this page?

Average rating:

 Based on 21 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
5 ratings

Tell us more